[Preventive measures against transfusion-associated complications and side effects]

Area of Science:

• Transfusion Medicine
• Immunology
• Infectious Disease Prevention

Background:

• Transfusion-associated risks have decreased significantly over the past thirty years.
• The introduction of nucleic acid testing (NAT) has been a key factor in this improvement.
• Ensuring blood transfusion safety remains a critical aspect of patient care.

Purpose of the Study:

• To highlight the advancements in reducing transfusion-associated risks.
• To explain the role of nucleic acid testing (NAT) in enhancing blood safety.
• To detail the components of compatibility testing for effective red cell concentrate (RCC) transfusions.

Main Methods:

• Review of current strategies for reducing transfusion risks.
• Explanation of the impact of nucleic acid testing (NAT) on blood unit safety.
• Description of compatibility testing procedures: ABO/Rh typing, alloantibody screening, and crossmatching.

Main Results:

• Significant reduction in transfusion-associated risks compared to thirty years ago.
• Lower risk of infection from contaminated blood units due to NAT.
• Compatibility testing ensures patient-donor red cell compatibility, minimizing adverse reactions.

Conclusions:

• Current strategies, particularly NAT, have markedly improved blood transfusion safety.
• Compatibility testing is essential for effective and safe red cell concentrate (RCC) transfusions.
• Ongoing vigilance in testing and procedures is vital for minimizing transfusion risks.